BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26681767)

  • 1. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
    Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
    Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
    Zeng X; Xu Z; Gu J; Huang H; Gao G; Zhang X; Li J; Jin H; Jiang G; Sun H; Huang C
    Mol Cancer Ther; 2016 Mar; 15(3):512-22. PubMed ID: 26832795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.
    Fang Y; Cao Z; Hou Q; Ma C; Yao C; Li J; Wu XR; Huang C
    Mol Cancer Ther; 2013 Aug; 12(8):1492-503. PubMed ID: 23723126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.
    Jiang G; Huang C; Li J; Huang H; Wang J; Li Y; Xie F; Jin H; Zhu J; Huang C
    Carcinogenesis; 2018 Mar; 39(3):482-492. PubMed ID: 29409027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
    Luo Y; Tian Z; Hua X; Huang M; Xu J; Li J; Huang H; Cohen M; Huang C
    Cell Mol Life Sci; 2020 Jan; 77(2):351-363. PubMed ID: 31222373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1.
    Liu X; Wang F; Tian L; Wang T; Zhang W; Li B; Bai YA
    Tumour Biol; 2016 Jun; 37(6):7921-8. PubMed ID: 26700671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isorhapontigenin (ISO) inhibited cell transformation by inducing G0/G1 phase arrest via increasing MKP-1 mRNA Stability.
    Gao G; Chen L; Li J; Zhang D; Fang Y; Huang H; Chen X; Huang C
    Oncotarget; 2014 May; 5(9):2664-77. PubMed ID: 24797581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
    Ghasemi A; Fallah S; Ansari M
    Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.
    Hua X; Xiang D; Guo M; Qian X; Chen R; Li T; Tian Z; Xu J; Huang C; Xie Q; Huang C
    Cell Death Dis; 2022 Aug; 13(8):753. PubMed ID: 36045117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
    Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.
    Li X; Gong X; Chen J; Zhang J; Sun J; Guo M
    Biochem Biophys Res Commun; 2015 May; 460(3):670-7. PubMed ID: 25817794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-429 suppresses glioblastoma multiforme by targeting SOX2.
    Dong H; Hao X; Cui B; Guo M
    Cell Biochem Funct; 2017 Jul; 35(5):260-268. PubMed ID: 28749077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.
    Fang B; Zhu J; Wang Y; Geng F; Li G
    Biomed Pharmacother; 2015 Oct; 75():148-52. PubMed ID: 26297548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.
    Jiang J; Huang J; Wang XR; Quan YH
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2278-84. PubMed ID: 27338052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.